0
Your cart

Your cart is empty

Books > Professional & Technical > Biochemical engineering > Biotechnology

Buy Now

Me Medicine vs. We Medicine - Reclaiming Biotechnology for the Common Good (Hardcover) Loot Price: R658
Discovery Miles 6 580
You Save: R104 (14%)
Me Medicine vs. We Medicine - Reclaiming Biotechnology for the Common Good (Hardcover): Donna Dickenson

Me Medicine vs. We Medicine - Reclaiming Biotechnology for the Common Good (Hardcover)

Donna Dickenson

 (sign in to rate)
List price R762 Loot Price R658 Discovery Miles 6 580 | Repayment Terms: R62 pm x 12* You Save R104 (14%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Personalized healthcare -- or what the award-winning author Donna Dickenson calls "Me Medicine" -- is radically transforming our longstanding "one-size-fits-all" model. Technologies such as direct-to-consumer genetic testing, pharmacogenetically developed therapies in cancer care, private umbilical cord blood banking, and neurocognitive enhancement claim to cater to an individual's specific biological character, and, in some cases, these technologies have shown powerful potential. Yet in others they have produced negligible or even negative results. Whatever is behind the rise of Me Medicine, it isn't just science. So why is Me Medicine rapidly edging out We Medicine, and how has our commitment to our collective health suffered as a result?

In her cogent, provocative analysis, Dickenson examines the economic and political factors fueling the Me Medicine phenomenon and explores how, over time, this paradigm shift in how we approach our health might damage our individual and collective well-being. Historically, the measures of "We Medicine," such as vaccination and investment in public-health infrastructure, have radically extended our life spans, and Dickenson argues we've lost sight of that truth in our enthusiasm for "Me Medicine."

Dickenson explores how personalized medicine illustrates capitalism's protean capacity for creating new products and markets where none existed before -- and how this, rather than scientific plausibility, goes a long way toward explaining private umbilical cord blood banks and retail genetics. Drawing on the latest findings from leading scientists, social scientists, and political analysts, she critically examines four possible hypotheses driving our Me Medicine moment: a growing sense of threat; a wave of patient narcissism; corporate interests driving new niche markets; and the dominance of personal choice as a cultural value. She concludes with insights from political theory that emphasize a conception of the commons and the steps we can take to restore its value to modern biotechnology.

General

Imprint: Columbia University Press
Country of origin: United States
Release date: June 2013
First published: June 2013
Authors: Donna Dickenson
Dimensions: 229 x 152 x 23mm (L x W x T)
Format: Hardcover - Trade binding
Pages: 296
ISBN-13: 978-0-231-15974-6
Categories: Books > Medicine > General issues > Health systems & services > General
Books > Professional & Technical > Biochemical engineering > Biotechnology > General
LSN: 0-231-15974-9
Barcode: 9780231159746

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners